Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2025-12-30 @ 1:36 PM
Study NCT ID:
NCT00047567
Status:
TERMINATED
Last Update Posted:
2015-12-14
First Post:
2002-10-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Open-label Adjunctive Zonisamide for Bipolar Disorder
Sponsor:
Elan Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-07
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2002-07
Completion Date Type:
None
First Submit Date:
2002-10-08
First Submit QC Date:
None
Study First Post Date:
2002-10-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-12-10
Last Update Post Date:
2015-12-14
Last Update Post Date Type:
ESTIMATED